Vaxcyte

PCVX

Market cap $6.48B

49.53 USD

+1.19

2.46%

At close Updated Nov 18, 4:00 PM EST

Pre-market

After hours

49.53

0.00

1 day

2.46%

5 days

9.05%

1 month

15.45%

3 months

54.35%

6 months

54.64%

Year to date

-40.54%

1 year

-42.73%

5 years

49.23%

10 years

89.41%

About: Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Employees: 414

Healthcare Biotechnology